Trials / Completed
CompletedNCT01685073
The Role of Sleep in the Treatment of Cannabis Use Disorders
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 127 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The number of people seeking treatment for marijuana-related problems is on the rise, yet there is no currently accepted medication proven to help them quit. Frequent marijuana users have reported that they have trouble sleeping when they try to quit, and that the loss of sleep can lead to relapse. This research is designed to measure the severity of sleep problems in people as they are trying to quit heavy use of marijuana, and to investigate whether extended-release zolpidem (Ambien CR®) can improve quit rates among people trying to stop using marijuana.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zolpidem extended-release | nightly administration of zolpidem extended-release |
| BEHAVIORAL | MET/CBT | a standardized 12-week therapy consisting of motivational enhancement therapy (MET) and cognitive behavior therapy (CBT) for treating cannabis use disorders will be administered to all study participants |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2018-07-01
- Completion
- 2018-07-01
- First posted
- 2012-09-13
- Last updated
- 2019-05-22
- Results posted
- 2019-05-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01685073. Inclusion in this directory is not an endorsement.